REG - Cranswick PLC - Director/PDMR Shareholding

CranswickAnnouncement

02/07/2020 15:35

RNS Number : 9018R
  
Cranswick PLC
  
02 July 2020
  
 

Director/PDMR Shareholding
Cranswick plc ("the Company")
The Company has been notified that the following award of LTIP nil-cost options has been made, pursuant to the Cranswick plc Long Term Incentive Plan (the "Scheme"), to certain Directors/Persons Discharging Managerial Responsibility ("PDMR") over ordinary shares of 10 pence each in the Company ("Ordinary Shares"), as follows:



Name


No. of Ordinary Shares subject to Option














Adam Couch


37,700




Mark Bottomley


24,900




Jim Brisby


24,900




Chris Aldersley


22,450













The nil-cost options were granted on 1 July 2020 in accordance with the Scheme and are based on a share price of 3562.67 pence per Ordinary Share, being the average quoted market price of the Company's shares on the three dealing days prior to the date of grant.
Vesting of the options is subject to the achievement of performance criteria based on growth in EPS (as regards 50% of the awards) and relative Total Shareholder Return (as regards 50% of each award).  The targets applying to each element are as follows.  
 











Target




EPS


Threshold


Average annual % growth in RPI + 3%




Maximum


Average annual % growth in RPI + 9%




TSR


Threshold


Median




Maximum


Upper decile



 
Tax qualifying options over 1,104 shares granted to each of the individuals named above on 1 June 2019 have been cancelled due to each individual already holding tax qualifying options as part of the August 2018 LTIP. No further tax qualifying options have been awarded in connection with the above award.
 
Enquiries:
Steven Glover, Company Secretary tel: 01482 275000


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
DSHEALXAEDFEEFA